Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma.
Cancers (Basel)
; 14(8)2022 Apr 13.
Article
in En
| MEDLINE
| ID: mdl-35454863
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Cancers (Basel)
Year:
2022
Document type:
Article